Literature DB >> 26061242

Isolation and Culturing of Glioma Cancer Stem Cells.

Sang-Soo Kim1, Kathleen F Pirollo1, Esther H Chang1.   

Abstract

In many human cancers including malignant glioblastoma multiforme (GBM), cancer stem cells (CSCs) are thought to be responsible for tumor initiation, metastasis and resistance to conventional anti-cancer therapies. Therefore, a CSC-targeted drug delivery strategy to eliminate CSCs is a desirable approach for developing a more effective therapeutic. Moreover, isolated CSCs will provide an invaluable tool for studying the underlying cellular mechanisms of tumor development and provide insight into therapeutic options for successful eradication of CSCs. This unit describes a method for the isolation and culture of CSCs from human GBM tumor tissue.
Copyright © 2015 John Wiley & Sons, Inc.

Entities:  

Keywords:  cancer stem cells; culture; glioblastoma multiforme; neurosphere; tumorsphere

Mesh:

Year:  2015        PMID: 26061242      PMCID: PMC4471477          DOI: 10.1002/0471143030.cb2310s67

Source DB:  PubMed          Journal:  Curr Protoc Cell Biol        ISSN: 1934-2616


  9 in total

1.  Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system.

Authors:  B A Reynolds; S Weiss
Journal:  Science       Date:  1992-03-27       Impact factor: 47.728

2.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

3.  Isolation, culture, and differentiation of progenitor cells from the central nervous system.

Authors:  Scott R Hutton; Larysa H Pevny
Journal:  CSH Protoc       Date:  2008-11-01

Review 4.  Malignant glioma: lessons from genomics, mouse models, and stem cells.

Authors:  Jian Chen; Renée M McKay; Luis F Parada
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

5.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

Authors:  Jeongwu Lee; Svetlana Kotliarova; Yuri Kotliarov; Aiguo Li; Qin Su; Nicholas M Donin; Sandra Pastorino; Benjamin W Purow; Neil Christopher; Wei Zhang; John K Park; Howard A Fine
Journal:  Cancer Cell       Date:  2006-05       Impact factor: 31.743

6.  Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon.

Authors:  V Tropepe; M Sibilia; B G Ciruna; J Rossant; E F Wagner; D van der Kooy
Journal:  Dev Biol       Date:  1999-04-01       Impact factor: 3.582

Review 7.  Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies.

Authors:  Per Ø Sakariassen; Heike Immervoll; Martha Chekenya
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

8.  Current strategies for identification of glioma stem cells: adequate or unsatisfactory?

Authors:  Paola Brescia; Cristina Richichi; Giuliana Pelicci
Journal:  J Oncol       Date:  2012-05-23       Impact factor: 4.375

9.  Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma.

Authors:  Patrizia Tunici; Lorena Bissola; Elena Lualdi; Bianca Pollo; Laura Cajola; Giovanni Broggi; Gabriella Sozzi; Gaetano Finocchiaro
Journal:  Mol Cancer       Date:  2004-10-06       Impact factor: 27.401

  9 in total
  6 in total

Review 1.  Multidimensional communication in the microenvirons of glioblastoma.

Authors:  Marike L Broekman; Sybren L N Maas; Erik R Abels; Thorsten R Mempel; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Rev Neurol       Date:  2018-08       Impact factor: 42.937

2.  Success of tumorsphere isolation from WHO grade IV gliomas does not correlate with the weight of fresh tumor specimens: an immunohistochemical characterization of tumorsphere differentiation.

Authors:  Kyoung Su Sung; Jin-Kyoung Shim; Ji-Hyun Lee; Se Hoon Kim; Sohee Park; Tae-Hoon Roh; Ju Hyung Moon; Eui-Hyun Kim; Sun Ho Kim; Su Jae Lee; Yong Min Huh; Seok-Gu Kang; Jong Hee Chang
Journal:  Cancer Cell Int       Date:  2016-09-27       Impact factor: 5.722

3.  Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.

Authors:  Sang-Soo Kim; Joe B Harford; Manish Moghe; Antonina Rait; Kathleen F Pirollo; Esther H Chang
Journal:  Nucleic Acids Res       Date:  2018-02-16       Impact factor: 16.971

4.  Lipid vesicles containing transferrin receptor binding peptide TfR-T12 and octa-arginine conjugate stearyl-R8 efficiently treat brain glioma along with glioma stem cells.

Authors:  Li-Min Mu; Ying-Zi Bu; Lei Liu; Hong-Jun Xie; Rui-Jun Ju; Jia-Shuan Wu; Fan Zeng; Yao Zhao; Jing-Ying Zhang; Wan-Liang Lu
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

5.  A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma.

Authors:  Brett W Stringer; Bryan W Day; Rochelle C J D'Souza; Paul R Jamieson; Kathleen S Ensbey; Zara C Bruce; Yi Chieh Lim; Kate Goasdoué; Carolin Offenhäuser; Seçkin Akgül; Suzanne Allan; Thomas Robertson; Peter Lucas; Gert Tollesson; Scott Campbell; Craig Winter; Hongdo Do; Alexander Dobrovic; Po-Ling Inglis; Rosalind L Jeffree; Terrance G Johns; Andrew W Boyd
Journal:  Sci Rep       Date:  2019-03-20       Impact factor: 4.379

6.  TLR4 interaction with LPS in glioma CD133+ cancer stem cells induces cell proliferation, resistance to chemotherapy and evasion from cytotoxic T lymphocyte-induced cytolysis.

Authors:  Fengyuan Che; Jiawei Yin; Yanchun Quan; Xiaoli Xie; Xueyuan Heng; Yifeng Du; Lijuan Wang
Journal:  Oncotarget       Date:  2017-06-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.